BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 75.20
+0.10 (0.13%)
Aug 12, 2025, 1:30 PM CST
Paramount Global Revenue
BIONET had revenue of 290.80M TWD in the quarter ending March 31, 2025, a decrease of -1.90%. This brings the company's revenue in the last twelve months to 1.22B, up 4.31% year-over-year. In the year 2024, BIONET had annual revenue of 1.22B with 8.40% growth.
Revenue (ttm)
1.22B
Revenue Growth
+4.31%
P/S Ratio
3.12
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.22B | 94.73M | 8.40% |
| Dec 31, 2023 | 1.13B | 146.93M | 14.99% |
| Dec 31, 2022 | 980.38M | 58.96M | 6.40% |
| Dec 31, 2021 | 921.42M | 114.85M | 14.24% |
| Dec 31, 2020 | 806.58M | 31.02M | 4.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 112.57M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Pegavision | 6.67B |